Lian Xiaoqiang, Li Haixia, Hao Jihong, Li Haixin, Xu Ling, Zhang Shuxia, Cao Li, Li Ruimin
Department of Clinical Laboratory, Handan Central Hospital, Handan, China.
Department of Anesthesiology, Handan Central Hospital, Handan, China.
Front Pediatr. 2025 Jul 25;13:1588675. doi: 10.3389/fped.2025.1588675. eCollection 2025.
INTRODUCTION: MYH9-related disease (MYH9-RD) is a rare autosomal dominant genetic syndrome characterized by congenital thrombocytopenia, with a risk of developing progressive nephropathy, sensorineural deafness, and presenile cataract. Due to its presentation of isolated thrombocytopenia, it is frequently misdiagnosed as immune thrombocytopenic purpura (ITP). METHODS: A 10-year-old girl with an initial diagnosis of ITP was evaluated, based on isolated thrombocytopenia and intermittent epistaxis. Clinical assessments included peripheral blood and bone marrow smear examinations to observe cellular morphology. Family history was collected to identify potential hereditary associations. Genetic testing was performed to detect potential pathogenic mutations. RESULTS: Peripheral blood and bone marrow smears revealed giant platelets, along with blue inclusions in neutrophils, eosinophils, and monocytes-key cytological features of MYH9-RD. Family history investigation showed thrombocytopenia in the patient's mother and maternal grandmother; additionally, the mother had mild hearing impairment, and the maternal grandmother had died of renal failure. Genetic testing confirmed the presence of the MYH9 p.E1841K mutation in the patient, which was inherited from her mother. Based on these findings, the diagnosis was revised from ITP to MYH9-RD. DISCUSSION: This case emphasizes that MYH9-RD should be considered in the differential diagnosis of unexplained thrombocytopenia, particularly when accompanied by characteristic cytological findings (e.g., giant platelets, blue inclusions in leukocytes) and a positive family history of related manifestations. The consistency of phenotypes within the affected family supports the importance of genetic screening and long-term follow-up for relatives of confirmed cases to enable early detection and management of potential complications.
引言:MYH9相关疾病(MYH9-RD)是一种罕见的常染色体显性遗传综合征,其特征为先天性血小板减少症,有发展为进行性肾病、感音神经性耳聋和早发性白内障的风险。由于其仅表现为孤立性血小板减少症,故常被误诊为免疫性血小板减少性紫癜(ITP)。 方法:对一名初诊为ITP的10岁女孩进行评估,该女孩表现为孤立性血小板减少症和间歇性鼻出血。临床评估包括外周血和骨髓涂片检查以观察细胞形态。收集家族史以确定潜在的遗传关联。进行基因检测以检测潜在的致病突变。 结果:外周血和骨髓涂片显示有巨大血小板,同时在中性粒细胞、嗜酸性粒细胞和单核细胞中可见蓝色包涵体,这些是MYH9-RD的关键细胞学特征。家族史调查显示患者的母亲和外祖母有血小板减少症;此外,母亲有轻度听力障碍,外祖母死于肾衰竭。基因检测证实患者存在MYH9 p.E1841K突变,该突变遗传自她的母亲。基于这些发现,诊断从ITP修订为MYH9-RD。 讨论:该病例强调,在不明原因血小板减少症的鉴别诊断中应考虑MYH9-RD,特别是当伴有特征性细胞学表现(如巨大血小板、白细胞中的蓝色包涵体)和相关表现的阳性家族史时。受影响家族中表型的一致性支持了对确诊病例亲属进行基因筛查和长期随访的重要性,以便能够早期发现和管理潜在并发症。
1993
BMJ Case Rep. 2025-6-24
Case Rep Hematol. 2025-7-10
1993
Res Pract Thromb Haemost. 2024-8-22
Hematology Am Soc Hematol Educ Program. 2017-12-8
Platelets. 2017-11-1
J Am Soc Nephrol. 2017-10-9